Julie Colin

Julie Colin has extensive work experience in the field of regulatory affairs. Julie is currently the Regulatory Affairs Regional Head EU/CH/US at OM Pharma since July 2021. Prior to this, they worked as a Senior Manager Regulatory Affairs at Stragen from February 2019 to July 2021. Julie also held positions at OM Pharma, where they worked as a Senior Manager Regulatory Affairs from April 2016 to February 2019, and as a Regulatory Affairs CMC Manager from May 2012 to March 2016. Before joining OM Pharma, they worked as a Regulatory Affairs Executive at Sanofi-Pasteur MSD from June 2010 to September 2011. Julie also gained experience as a Regulatory Affairs Pharmacist at Arrow Génériques from January 2008 to June 2010, and at Bayer HealthCare from November 2006 to October 2007. Julie started their career at sanofi-aventis as a Resident detached in Pharmaceutical Company - Regulatory Affairs from May 2005 to October 2006.

Julie Colin pursued their education from 1997 to 2007 at the University of Montpellier, where they obtained a Diplôme d'Etat de Docteur en Pharmacie. The specific field of study for this degree is not mentioned. In 2004, they attended the University of Lille 1 Sciences and Technology, completing a Master Professionnel in Affaires Réglementaires et Pharmaceutiques in 2005.